The Southwest and Wales Advanced Therapies Network (SWAT) brings together academic, industry and clinical stakeholders working on cell and gene-based therapies in Southwest England and Wales.
Southwest and Wales Advanced Therapies Network
About the network
The network was established in 2020 as part of the UK Advanced Therapies (UKAT) initiative. It aims to drive collaboration, innovation and strategic dialogue, and create connections with the wider UK and international Advanced Therapies communities.
The SWAT network aims to raise the profile of the region’s advanced therapy strengths, and to help translate the potential of this technology into patient benefits.
This is through hosting open events and networking opportunities to discuss advanced therapies innovation, commercialisation and clinical delivery, and provides networking opportunities. These cover subjects such as clinical trials, investment, regulatory affairs and academic translation. The SWAT network also promotes several UK Advanced Therapies initiatives that fund cross-institution academic collaboration and collaborative projects between commercial partners and academic/NHS research groups.
Who is this network for?
Academics, industry, NHS, government, charities, funders, R&D, and commercial support sectors working in the discovery, development and delivery of advanced therapies.
What organisations are involved in this network?
SWAT partners include the Universities of Bristol, Bath, Cardiff, Swansea, and Plymouth; NHS Blood & Transplant; Advanced Therapies Wales and Life Sciences Hub Wales, as well as regional advanced therapies biotech companies.
How can people get involved?
Membership is free. To join the mailing list, please visit the SWAT network website.